Antibody-directed enzyme prodrug therapy for cancer: its theoretical basis and application
- 1 December 1995
- journal article
- Published by Elsevier in Molecular Medicine Today
- Vol. 1 (9) , 424-431
- https://doi.org/10.1016/s1357-4310(95)90815-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Clinical issues in antibody designTrends in Biotechnology, 1995
- Antibody directed enzyme prodrug therapy (ADEPT)Annals of Oncology, 1994
- Radiolabeled antibody therapy of lymphomaPublished by Springer Nature ,1993
- Man-made antibodiesNature, 1991
- Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancerBritish Journal of Cancer, 1989
- The First Bagshawe lecture: Towards generating cytotoxic agents at cancer sitesBritish Journal of Cancer, 1989
- A cytotoxic agent can be generated selectively at cancer sitesBritish Journal of Cancer, 1988
- Antibody directed enzymes revive anti-cancer prodrugs conceptBritish Journal of Cancer, 1987
- Mapping epitope characteristics on carcinoembryonic antigenBritish Journal of Cancer, 1986
- Selective Destruction of Target Cells by Diphtheria Toxin Conjugated to Antibody Directed against Antigens on the CellsScience, 1970